رجوع
نطاق اليوم
KWD 46.75
KWD 48.67
نطاق 52 أسبوعًا
KWD 13.22
KWD 94.90
حجم التداول
767,602
متوسط 50 يوم / 200 يوم
KWD 71.72
/
KWD 40.61
الإغلاق السابق
KWD 49.06
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -19.2 | 0.3 |
| P/B | 1.8 | 2.9 |
| ROE % | -11.9 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 116.710
+148.1%
Low: KWD 90.000
High: KWD 145.000
ربحية السهم المستقبلية
-KWD 1.721
الإيرادات المقدّرة
7.1 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 1.603
KWD 1.603 – KWD 1.603
|
850 M | 2 |
| FY2029 |
-KWD 0.308
-KWD 0.308 – -KWD 0.308
|
630 M | 4 |
| FY2028 |
-KWD 1.907
-KWD 4.040 – KWD 1.237
|
210 M | 6 |
النقاط الرئيسية
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -225.81M
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-11.86%
ROIC-14.16%
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
0.00
Current Ratio24.81
Interest Coverage0.00
التقييم
P/E Ratio
-19.18
P/B Ratio1.79
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -141.20M |
| ROE | -11.86% | ROA | -8.91% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -225.81M |
| ROIC | -14.16% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 24.81 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -19.18 | P/B Ratio | 1.79 |
| P/S Ratio | N/A | PEG Ratio | -11.37 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.71B | Enterprise Value | 1.91B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -141.20M | -122.53M | -89.62M | -51.32M | -40.01M |
| EPS (Diluted) | -2.40 | -2.34 | -2.43 | -1.44 | -1.20 |
| Gross Profit | -3.90M | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -287.57M | -158.23M | -102.78M | -52.56M | -37.70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.58B | 903.33M | 482.02M | 97.85M | 111.16M |
| Total Liabilities | 67.54M | 38.49M | 29.05M | 212.99M | 175.89M |
| Shareholders' Equity | 1.52B | 864.84M | 452.97M | -115.14M | -64.74M |
| Total Debt | 6.49M | 3.86M | 5.45M | 260,000.0 | 621,000.0 |
| Cash & Equivalents | 799.62M | 169.51M | 129.79M | 26.09M | 105.31M |
| Current Assets | 1.57B | 891.21M | 473.61M | 93.09M | 109.25M |
| Current Liabilities | 63.29M | 36.02M | 24.74M | 13.01M | 8.66M |